| Spherical nucleic acid nanoparticles: therapeutic potential CH Kapadia, JR Melamed, ES Day BioDrugs 32 (4), 297-309, 2018 | 101 | 2018 |
| Nanoparticulate immunotherapy for cancer CH Kapadia, JL Perry, S Tian, JC Luft, JM DeSimone Journal of Controlled Release 219, 167-180, 2015 | 96 | 2015 |
| Layer‐by‐layer assembled PLGA nanoparticles carrying miR‐34a cargo inhibit the proliferation and cell cycle progression of triple‐negative breast cancer cells CH Kapadia, SA Ioele, ES Day Journal of biomedical materials research Part A 108 (3), 601-613, 2020 | 44 | 2020 |
| Nanoparticle delivery of chemosensitizers improve chemotherapy efficacy without incurring additional toxicity JM Caster, M Sethi, S Kowalczyk, E Wang, X Tian, SN Hyder, KT Wagner, ... Nanoscale 7 (6), 2805-2811, 2015 | 43 | 2015 |
| Pulmonary delivery of nanoparticle-bound toll-like receptor 9 agonist for the treatment of metastatic lung cancer JL Perry, S Tian, N Sengottuvel, EB Harrison, BK Gorentla, CH Kapadia, ... ACS nano 14 (6), 7200-7215, 2020 | 40 | 2020 |
| Polymer nanocarriers for MicroRNA delivery CH Kapadia, B Luo, MN Dang, ND Irvin‐Choy, DM Valcourt, ES Day Journal of applied polymer science 137 (25), 48651, 2020 | 39 | 2020 |
| Reduction sensitive PEG hydrogels for codelivery of antigen and adjuvant to induce potent CTLs CH Kapadia, S Tian, JL Perry, JC Luft, JM DeSimone Molecular pharmaceutics 13 (10), 3381-3394, 2016 | 39 | 2016 |
| Layer-by-layer assembled gold nanoshells for the intracellular delivery of miR-34a R Goyal, CH Kapadia, JR Melamed, RS Riley, ES Day Cellular and molecular bioengineering 11, 383-396, 2018 | 33 | 2018 |
| Extending antigen release from particulate vaccines results in enhanced antitumor immune response CH Kapadia, S Tian, JL Perry, D Sailer, JC Luft, JM DeSimone Journal of Controlled Release 269, 393-404, 2018 | 31 | 2018 |
| Role of linker length and antigen density in nanoparticle peptide vaccine CH Kapadia, S Tian, JL Perry, JC Luft, JM DeSimone ACS omega 4 (3), 5547-5555, 2019 | 24 | 2019 |
| Best practices for preclinical in vivo testing of cancer nanomedicines DM Valcourt, CH Kapadia, MA Scully, MN Dang, ES Day Advanced healthcare materials 9 (12), 2000110, 2020 | 18 | 2020 |
| Quantification of Gold Nanoparticles Using the NanoDrop One Microvolume UV-Vis Spectrophotometer CH Kapadia, JR Melamed, ES Day Thermo Fisher Scientific: Waltham, MA, USA, 2019 | 3 | 2019 |
| Nanotargeting to the kidney RM Williams, C Kapadia, EA Jaimes, DA Heller Regenerative Nephrology, 439-449, 2022 | 2 | 2022 |
| Toll-like receptor agonist modified particles and their use in lung cancer TR Joseph M. Desimone, Jillian PERRY, Chintan KAPADIA, Shaomin TIAN, James ... WO Patent WO/2018/207,153, 2018 | | 2018 |
| Engineering print® nanoparticle subunit vaccine to induce antitumor immune response CH Kapadia The University of North Carolina at Chapel Hill, 2016 | | 2016 |
| Particles that enhance immune responses by increasing cytotoxic t-cell function or production of interferon gamma therefrom JP Joseph Desimone, Chintan KAPADIA, Shaomin TIAN US Patent WO2015153632A1, 2015 | | 2015 |
| Nanoparticle chemosensitization M Sethi, S Kowalczyk, E Wang, C Kapadia, A Wang International Journal of Radiation Oncology, Biology, Physics 87 (2), S648-S649, 2013 | | 2013 |
| P4‐030: Elevated Amyloid‐beta Impairs Protein Sumoylation L Lee, E Dale, A Staniszewski, H Zhang, F Michelassi, M Sakurai, ... Alzheimer's & Dementia 6, e29-e29, 2010 | | 2010 |
